These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Listed as ongoing, but also has a completion date||2006-006950-81||A Phase 3 study of safety and efficacy of Karenitecin versus topotecan administered for 5 consecutive days every 3 weeks in patients with advanced epithelial ovarian cancer||2013-05-07||bad-data|
|Not reported Terminated||2009-012983-14||Randomized, multicenter, double-blind, phase 3 trial of Tavocept versus Placebo in patients with newly diagnosed or relapsed advanced primary adenocarcinoma of the lung treated with docetaxel or pacli...||2013-04-22||due-trials|